Sartorius Stedim Biotech SA / Key word (s): Expansion Sartorius Stedim Biotech expands manufacturing and R&D capacities for innovative bioprocess solutions in France 17-Jun-2025 / 16:00 CET/CEST ...

To meet the growing demand for single-use bioprocessing solutions, Sartorius Stedim Biotech almost doubled ... labs for fluid management and cell culture technologies, as well as application ...

Sartorius Stedim Biotech S.A. engages in the production ... The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Sartorius Stedim Biotech S.A. + Watchlist DIM FR Open Last Updated: May 27, 2025 4:40 p.m. CEDT Delayed quote ...

A UK biotech firm spent years gathering genetic data that has uncovered 1 million previously unknown microbial species and ...

TCG Labs Soleil’s Juri Biosciences is offering EpimAb Biotherapeutics up to $210 million biobucks for exclusive licensing rights to the China biotech’s T-cell engager designed to treat ...